» Articles » PMID: 1328066

Reproductive Factors and the Risk of Hepatocellular Carcinoma in Women

Overview
Journal Int J Cancer
Specialty Oncology
Date 1992 Sep 30
PMID 1328066
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The relationship between reproductive factors and the risk of primary liver cancer was analyzed using data of a case-control study conducted in Northern Italy between 1984 and 1991 on 79 women with histologically or serologically confirmed hepatocellular carcinoma and 344 controls in hospital for a wide spectrum of acute, non-neoplastic diseases. The multivariate relative risk (RR) for parous vs. nulliparous women was 2.6 (95% confidence interval (CI) 1.2 to 5.8), and the risk increased with parity from 2.1 for 1, to 2.6 for 2, to 3.2 for 3, to 3.5 for 4 or more births (chi 2(1) trend = 6.49, p = 0.01). The relative risks were above unity, though not significantly, in women reporting spontaneous (RR = 1.3) and induced (RR = 1.6) abortions, and there was a significant trend in risk with total number of abortions. An apparent inverse trend in risk with age and first birth was accounted for by parity. No relationship emerged with age at menarche, at menopause or other menstrual factors. The association between parity and hepatocellular carcinoma was, if anything, more marked at older ages, since the RR was 1.6 (95% CI 0.5 to 4.6) below age 60, and 4.8 (95% CI 1.3 to 18.1) at age 60 or over. This observation has relevant public-health implications, since in developed countries primary liver cancer is extremely rare among young women, but not at older ages. The association between parity and hepatocellular carcinoma is similar to that described for combined oral contraceptives, again confirming that the impact of contraceptives on the risk of several neoplasms is similar to that of pregnancy.

Citing Articles

Menstrual Factors, Reproductive History and Liver Cancer Risk: Findings from a Prospective Cohort Study in Chinese Women.

Tuo J, Li H, Wang J, Fang J, Tan Y, Xiang Y Cancer Epidemiol Biomarkers Prev. 2022; 31(11):2046-2053.

PMID: 35984984 PMC: 9633397. DOI: 10.1158/1055-9965.EPI-22-0439.


Domperidone use and risk of primary liver cancer in the Clinical Practice Research Datalink.

Thistle J, Petrick J, Yang B, Bradley M, Graubard B, McGlynn K Cancer Epidemiol. 2018; 55:170-175.

PMID: 29986235 PMC: 7008444. DOI: 10.1016/j.canep.2018.06.009.


Age-specific sex difference in the incidence of hepatocellular carcinoma in the United States.

Liu P, Xie S, Hu S, Cheng X, Gao T, Zhang C Oncotarget. 2017; 8(40):68131-68137.

PMID: 28978103 PMC: 5620243. DOI: 10.18632/oncotarget.19245.


Reproductive factors, exogenous hormone use and risk of hepatocellular carcinoma among US women: results from the Liver Cancer Pooling Project.

McGlynn K, Sahasrabuddhe V, Campbell P, Graubard B, Chen J, Schwartz L Br J Cancer. 2015; 112(7):1266-72.

PMID: 25742475 PMC: 4385955. DOI: 10.1038/bjc.2015.58.


Impact of sex on the survival of patients with hepatocellular carcinoma: a Surveillance, Epidemiology, and End Results analysis.

Yang D, Hanna D, Usher J, LoCoco J, Chaudhari P, Lenz H Cancer. 2014; 120(23):3707-16.

PMID: 25081299 PMC: 9191612. DOI: 10.1002/cncr.28912.